Kulanka 8aad ee Wadajirka ah ACTRIMS-ECTRIMS 2020 (Muqaal)

WAAD KA HELI DOONTAA MASHRUUCA VIA NOLOSHA KHUDBADDA LAGU SOO SAARO (DEGDEG AH)

Kulankii 8aad ee Wadajirka ah ACTRIMS-ECTRIMS

8 The^th Kulanka Wadajirka ah ACTRIMS-ECTRIMS, shirka caalamiga ah ee ugu weyn ee diiradda lagu saaray cilmi-baarista Multiple Sclerosis (MS), ayaa loo qabtay qaab muuqaal ah Sebtembar 11-13, 2020, oo leh fadhi xanbaarsan oo gaar ah oo ka muuqda Wararkii ugu dambeeyay ee COVID-19 iyo kulan ku saabsan September 26.

Seddexdii sanaba hal mar, ACTRIMS iyo ECTRIMS waxay qabanqaabiyaan kulan wadajir ah si ay u dhiirigeliyaan isdhaafsiga aqoonta ayna isu keenaan xirfadlayaal ka kala socda adduunka oo dhan.

Marka la eego saameynta caalamiga ah ee COVID-19, Shirkii 8aad ee Wadajirka ah ACTRIMS-ECTRIMS wuxuu u dhacay gabi ahaanba. Arag dhammaan fadhiyada sayniska, boodhadhka elektaroonigga ah iyo koorsooyinka waxbaridda ee MSVirtual2020. 

Shirkan casriga ah - MSVirtual2020 - Saynisyahano heer caalami ah, dhakhaatiirta neerfaha, dhakhaatiirta iyo cilmi-baarayaasha adduunka oo dhan ayaa soo bandhigay cilmi-baaristii ugu dambeysay, natiijooyinka tijaabada caafimaadka iyo tignoolajiyada iyo horumarka ogaanshaha ee sclerosis badan (MS).

Mawduucyada muhiimka ah waxaa ka mid ahaa:

• Cilmi-baadhis heersare ah oo lagu sameeyay sababta MS, oo u dhaxaysa epigenetics iyo arrimaha hidde-sideyaasha, si loo qeexo dariiqyada difaaca jirka iyo cudurrada faafa ee qallafsan ee ogeysiiya helitaanka daroogada iyo faragelinta daaweynta.
• Horumarka shucaaca iyo hababka barashada mashiinka iyo sida farsamooyinkani ay nooga caawin karaan inaan si wanaagsan u fahanno MS.
• Biomarkers ee dhaqdhaqaaqa jirrada iyo ka jawaab celinta daawaynta, taas oo muhiim u ah mustaqbalka daawaynta shakhsi ahaaneed ee MS.
• Natiijooyinka tijaabooyinkii bukaan-socodka ee u dambeeyay ee wakiilada iyo dhexgalka cusub, hal-abuurka daaweynta calaamadaha iyo dhaqancelinta, iyo cilmi-baarista hadda ee MS iyo COVID-19.

Barashada & Ujeeddooyinka Barnaamijka

Mawduucyada shirkan, oo ay nashqadeeyeen Guddiga Barnaamijka Sayniska ee MSVirtual2020 waa bukaan-socod, cudur-sidaha, tarjumaada, iyo arrimaha deegaanka/ hidaha waxaana laga soo qaatay soo-galitaanka ka qaybgalayaashii hore iyo daraasado iyo suugaanta soo ifbaxaya.
MSVirtual2020 meelaha muhiimka ah ee waxbarashada:

• Xeeladaha daweynta ee lagu xakameynayo dhaqdhaqaaqa cudurka iyo uruurinta naafanimada ee shakhsiyaadka qaba xanuunka shucaaca ee go'doonsan, dib u soo noqoshada MS iyo horumarka MS
• Waxtarka daawaynta wax ka beddelka cudurrada hadda ee qaybaha bukaan-socodka ee shakhsiyaadka qaba MS
• Doorka unugyada difaaca jirka ee dhalanteed ee waddooyinka cudur-sidaha iyo dib u hagaajinta ee MS
• Xiriirka ka dhexeeya mindhicirka, microbiome, iyo dhaqdhaqaaqa cudurka ee shakhsiyaadka qaba MS
• Horumarrada sawirka iyo cabbiraadaha nidaamka aragga ee ogaanshaha, saadaasha iyo la socodka shakhsiyaadka qaba MS
• Isku dhafka macluumaadka ku saabsan deegaanka, qaab nololeedka, da'da la xiriirta, iyo arrimaha hiddaha/epigenetic ee khatarta MS iyo koorsada caafimaad
• Isticmaalka hababka barashada mashiinka saadaasha khatarta MS iyo koorsada caafimaad

Kulamada waxaa ka mid ahaa:

1. BD01 – DMT-yadu waxay ka hortagaan- gaabis garaadka daciifka ah ee MS
2. BD02 - DMTs waa in lagu tijaabiyaa shakhsiyaadka qaba PPMS iyo SPMS oo leh ama aan lahayn hawlo cudur dhawaan
3. BD03 - Microglia waxay difaac u yihiin MS
4. CS01 - European Charcot Foundation Symposium; Sida kor loogu qaado remyelination ee MS
5. FC01 – Isgaarsiin bilaash ah 1
6. FC02 – Isgaarsiin bilaash ah 2
7. FC03 – Isgaarsiin bilaash ah 3
8. FC04 – Isgaarsiin bilaash ah 4
9. HT01 – Mawduuca Kulul 1- Xeeladaha kor loogu qaadayo dib u soo kabashada
10. HT02 – Mawduuca Kulul 2- Gabowga iyo MS
11. HT03 – Mawduuca Kulul 3- Kobcinta caafimaadka carruurta ee MS
12. HT04 – Mawduuca Kulul 4- Cilmiga cudurka cawliga
13. HT05 – Mawduuca Kulul 5- Lymphoid follicles iyo ku lug lahaanshaha meningeal ee MS
14. HT06 – Mawduuca Kulul 6- Aragtida caalamiga ah ee NMOSD
15. HT07 – Mawduuca Kulul 7- Cudurka dhexdhexaadinta MOG
16. LB01 – Warar deg deg ah
17. MTE01 - CNS ee cilladaha carruurta
18. MTE02 - Neuro-ophthalmology ee MS
19. MTE03 - daawaynta ku hagta B-cell ee MS
20. MTE04 - Doorashada saxda ah ee daaweynta cudurka MS ee bukaannada gaarka ah
21. MTE05 - Xanuunada difaaca CNS ee aan ahayn MS
22. NS01 – Kalkaaliyaasha Kalfadhiga 1- Hawlaha kalkaalinta sare
23. NS02 – Kalkaaliyaasha Kalfadhiga 2- Wax ku darsiga gaarka ah ee kalkaalinta MS
24. PL01 – Casharka Guud ee 1- Soo Dhawaynta iyo Muxaadarada Paty
25. PL02 - Casharka Guud 2- ACTRIMS-ECTRIMS Muxaadaro iyo xidhidh
26. PS01 - Xeeladaha wax ka beddelka cudurka
27. PS02 - Difaaca jirka ee MS pathology iyo dayactirka
28. PS03 - Biomarkers
29. PS04 - Saamaynta deegaanka iyo qaab nololeedka iyo khatarta MS iyo koorsada caafimaad
30. PS05 - Maaraynta dawooyinka ee MS ee horumarka leh
31. PS06 - Qaybaha Lymphocyte ee MS
32. PS07 - Horumarka shucaaca I (NAIMS-MAGNIMS)
33. PS08 - Epigenetics iyo arrimaha hiddaha
34. PS09 - Hababka la gaaryeelay ee MS
35. PS10 - dhidibka Gut-CNS iyo microbiome-ka ku jira MS
36. PS11 - Horumarka shucaaca II
37. PS12 - Arrimaha galmada la xidhiidha ee pathogenesis iyo maamulka
38. PS13 - Wax cusub oo ku saabsan daaweynta calaamadaha iyo dhaqancelinta
39. PS14 - Saamaynta MS ee neurons iyo glia
40. PS15 - Qiyaasaha natiijada muuqaalka ee MS (IMSVISUAL)
41. PS16 - hababka barashada mashiinka
42. SS02 - Kulan Gaar ah- COVID-19
43. YI01 - Baarayaasha da'da yar 1
44. YI02 - Baarayaasha da'da yar 2